why choose us

First received: January 09, 2023

Clinical Trial: Liposomal Bupivacaine and Transoral Robotic Surgery

Study Status: Completed

Recruit Status: RECRUITING

Condition: Oropharyngeal Cancer

Study Type: OBSERVATIONAL


Official Title: Impact of Liposomal Bupivacaine on Post-operative Pain, Opioid Use, and Swallow Function in Transoral Robotic Surgery

Brief Summary: This study is for patients with oropharyngeal squamous cell carcinoma.We want to learn more about how we can optimize pain control in patients who undergo transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma.Our goal is to determine if a local anesthetic called EXPAREL® (Liposomal Bupivacaine) impacts postsurgical pain and swallow function in patients with oropharyngeal squamous cell carcinoma undergoing TORS.EXPAREL® is an FDA-approved anesthetic drug that provides long-lasting and precise…

Read more